AJP - Lung AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (November 30, 2007). doi:10.1152/ajplung.00243.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/L300    most recent
00243.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, B.
Right arrow Articles by Hellman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, B.
Right arrow Articles by Hellman, J.
Submitted on June 25, 2007
Accepted on November 27, 2007

Activation of Toll-Like Receptor 2 Impairs Hypoxic Pulmonary Vasoconstriction in Mice

Bodil Petersen1, Kenneth D. Bloch2, Fumito Ichinose1, Hae-Sook Shin3, Misako Shigematsu3, Aranya Bagchi1, Warren M Zapol4, and Judith Hellman2*

1 Anesthesia and Critical Care, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
2 Anesthesia and Critical Care and Internal Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
3 Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts, United States
4 Anesthesia & Critical Care, Harvard Medical School, Massachausetts General Hospital, Boston, Massachusetts, United States

* To whom correspondence should be addressed. E-mail: jhellman{at}partners.org.

Toll-like receptors (TLRs) mediate inflammation in sepsis, but their role in sepsis-induced respiratory failure is unknown. Hypoxic pulmonary vasoconstriction (HPV) is a unique vasoconstrictor response that diverts blood flow away from poorly ventilated lung regions. HPV is impaired in sepsis and after challenge with the TLR4 agonist, lipopolysaccharide (LPS). Unlike TLR4 agonists, which are present only in Gram-negative bacteria, TLR2 agonists are ubiquitously expressed in all of the major classes of microorganisms that cause sepsis, including both Gram-positive and Gram-negative bacteria, and fungi. We tested the hypothesis that Pam3Cys, a TLR2 agonist, impairs HPV, and compared selected pulmonary and systemic effects of Pam3Cys versus LPS. HPV was assessed 22 hours after challenge with saline, Pam3Cys, or LPS by measuring the increase in the pulmonary vascular resistance of the left lung before and during left lung alveolar hypoxia produced by left mainstem bronchus occlusion (LMBO). Additional endpoints included arterial blood gases during LMBO, hemodynamic parameters, weight loss, temperature, physical appearance, and several markers of lung inflammation. Compared with saline, challenge with Pam3Cys caused profound impairment of HPV, reduced systemic arterial oxygenation during LMBO, weight loss, leukopenia, and lung inflammation. In addition to these effects, LPS-challenged mice had lower rectal temperatures, metabolic acidosis, and were more ill appearing than Pam3Cys-challenged mice. These data indicate that TLR2 activation impairs HPV and induces deleterious systemic effects in mice, and suggest that TLR2 pathways may be important in sepsis-induced respiratory failure.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.